Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tricortin 1000 in Chronic Low Back Pain
NCT04585334Phase 4Recruiting
- Sponsor
- Fidia Farmaceutici
- Start
- Mar 2019
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tricortin in chronic low back pain (CLBP) (3 arms), sponsored by Fidia Farmaceutici. Primary endpoint: Numerical Rating Scale for pain at Day 15. Started Mar 2019; status: recruiting.
02
Drugs
Tricortin
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT04585334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585334.